文献速递前列腺癌

专家与超级专家:机器人辅助根治性前列腺切除术的自动性能指标与临床结果差异

Experts vs super-experts: differences in automated performance metrics and clinical outcomes for robot-assisted radical prostatectomy.
PubMed 文献 · BJU Int · 2018-11-18

本研究比较了专家(100-750例)与超级专家(2100-3500例)在机器人辅助根治性前列腺切除术四个关键步骤中的自动性能指标(APMs)及临床结局。超级专家在部分APMs上存在差异,且围手术期结果更优:淋巴结产量更高(22.6 vs 14.9枚)、失血量更少(125 vs 130 mL)、30天再入院率更低(1% vs 13%)。肿瘤学和功能学结局呈现相似但非显著趋势。

要点

  • 超级专家在RARP四个关键步骤的部分APMs上与专家存在显著差异。
  • 超级专家围手术期结果更优:淋巴结产量更高、失血量更少、再入院率更低。
  • 肿瘤学和功能学结局趋势有利于超级专家但未达统计学显著性。

核心结论

  • 专家与超级专家在RARP四个关键步骤的部分APMs上存在显著差异,表明外科医生在达到专家水平后仍持续提升表现。

研究设计与样本

  • 研究纳入125例机器人辅助根治性前列腺切除术,采集APMs(运动追踪和系统事件数据)并同步手术视频。
  • 比较专家(100-750例)与超级专家(2100-3500例)两个经验水平,使用多水平混合效应模型分析APMs和临床结局。

主要发现

  • 超级专家在四个关键步骤的部分APMs上与专家存在差异(P < 0.05)。
  • 超级专家淋巴结产量更高(22.6 vs 14.9枚,P < 0.01),失血量更少(125 vs 130 mL,P < 0.01),30天再入院率更低(1% vs 13%,P = 0.02)。
  • 生化复发率(5% vs 15%,P = 0.13)和3个月控尿率(36% vs 18%,P = 0.14)在超级专家中呈现有利趋势但未达统计学显著性。

临床怎么用

  • APMs可用于区分不同经验水平外科医生的手术表现,并可能为个体化培训提供依据。
  • 超级专家的围手术期优势提示持续学习和技术精进可改善患者结局。

局限性

  • 肿瘤学和功能学结局的差异未达统计学显著性,需更大样本验证。
  • 研究为观察性设计,APMs与临床结局的因果关系尚未明确。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To evaluate automated performance metrics (APMs) and clinical data of experts and super-experts for four cardinal steps of robot-assisted radical prostatectomy (RARP): bladder neck dissection; pedicle dissection; prostate apex dissection; and vesico-urethral anastomosis. SUBJECTS AND METHODS: We captured APMs (motion tracking and system events data) and synchronized surgical video during RARP. APMs were compared between two experience levels: experts (100-750 cases) and super-experts (2100-3500 cases). Clinical outcomes (peri-operative, oncological and functional) were then compared between the two groups. APMs and outcomes were analysed for 125 RARPs using multi-level mixed-effect modelling. RESULTS: For the four cardinal steps selected, super-experts showed differences in select APMs compared with experts (P < 0.05). Despite similar PSA and Gleason scores, super-experts outperformed experts clinically with regard to peri-operative outcomes, with a greater lymph node yield of 22.6 vs 14.9 nodes, respectively (P < 0.01), less blood loss (125 vs 130 mL, respectively; P < 0.01), and fewer readmissions at 30 days (1% vs 13%, respectively; P = 0.02). A similar but nonsignificant trend was seen for oncological and functional outcomes, with super-experts having a lower rate of biochemical recurrence compared with experts (5% vs 15%, respectively; P = 0.13) and a higher continence rate at 3 months (36% vs 18%, respectively; P = 0.14). CONCLUSION: We found that experts and super-experts differed significantly in select APMs for the four cardinal steps of RARP, indicating that surgeons do continue to improve in performance even after achieving expertise. We hope ultimately to identify associations between APMs and clinical outcomes to tailor interventions to surgeons and optimize patient outcomes.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Hung AJ, Oh PJ, Chen J, et al. Experts vs super-experts: differences in automated performance metrics and clinical outcomes for robot-assisted radical prostatectomy. BJU Int. 2018. PMID: 30358042. doi:10.1111/bju.14599

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。